BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36417933)

  • 1. Development of Differentiating Infected from Vaccinated Animals (DIVA) Real-Time PCR for African Horse Sickness Virus Serotype 1.
    Wang Y; Ong J; Ng OW; Songkasupa T; Koh EY; Wong JPS; Puangjinda K; Fernandez CJ; Huangfu T; Ng LC; Chang SF; Yap HH
    Emerg Infect Dis; 2022 Dec; 28(12):2446-2454. PubMed ID: 36417933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic DIVA tests accompanying the Disabled Infectious Single Animal (DISA) vaccine platform for African horse sickness.
    van Rijn PA; Maris-Veldhuis MA; Boonstra J; van Gennip RGP
    Vaccine; 2018 Jun; 36(25):3584-3592. PubMed ID: 29759377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VP2 Exchange and NS3/NS3a Deletion in African Horse Sickness Virus (AHSV) in Development of Disabled Infectious Single Animal Vaccine Candidates for AHSV.
    van de Water SG; van Gennip RG; Potgieter CA; Wright IM; van Rijn PA
    J Virol; 2015 Sep; 89(17):8764-72. PubMed ID: 26063433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants.
    van Rijn PA; Maris-Veldhuis MA; Grobler M; Wright IM; Erasmus BJ; Maartens LH; Potgieter CA
    Vaccine; 2020 Oct; 38(45):7108-7117. PubMed ID: 32921506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic applications of molecular and serological assays for bluetongue and African horse sickness.
    Mayo CE; Weyer CT; Carpenter MJ; Reed KJ; Rodgers CP; Lovett KM; Guthrie AJ; Mullens BA; Barker CM; Reisen WK; MacLachlan NJ
    Rev Sci Tech; 2021 Jun; 40(1):91-104. PubMed ID: 34140738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform.
    van Rijn PA; Maris-Veldhuis MA; Potgieter CA; van Gennip RGP
    Vaccine; 2018 Apr; 36(15):1925-1933. PubMed ID: 29525278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Luminex-Based DIVA Assay for Serological Detection of African Horse Sickness Virus in Horses.
    Sánchez-Matamoros A; Nieto-Pelegrín E; Beck C; Rivera-Arroyo B; Lecollinet S; Sailleau C; Zientara S; Sánchez-Vizcaíno JM
    Transbound Emerg Dis; 2016 Aug; 63(4):353-9. PubMed ID: 27090377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African horse sickness outbreaks caused by multiple virus types in Ethiopia.
    Aklilu N; Batten C; Gelaye E; Jenberie S; Ayelet G; Wilson A; Belay A; Asfaw Y; Oura C; Maan S; Bachanek-Bankowska K; Mertens PP
    Transbound Emerg Dis; 2014 Apr; 61(2):185-92. PubMed ID: 23083078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
    Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
    Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real time RT-PCR assays for detection and typing of African horse sickness virus.
    Bachanek-Bankowska K; Maan S; Castillo-Olivares J; Manning NM; Maan NS; Potgieter AC; Di Nardo A; Sutton G; Batten C; Mertens PP
    PLoS One; 2014; 9(4):e93758. PubMed ID: 24721971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Genome Analysis of All Nine African Horse Sickness Serotypes Isolated From Equine Fatalities in Kenya and South Africa.
    Hoffmann B; Joseph S; Patteril NAG; Caveney MR; Elizabeth SK; Muhammed R; Wernery R; Wernery U
    J Equine Vet Sci; 2022 Dec; 119():104137. PubMed ID: 36223818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
    Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
    BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. African horse sickness.
    Zientara S; Weyer CT; Lecollinet S
    Rev Sci Tech; 2015 Aug; 34(2):315-27. PubMed ID: 26601437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using a new serotype-specific Polymerase Chain Reaction (PCR) and sequencing to differentiate between field and vaccine-derived African Horse Sickness viruses submitted in 2016/2017.
    van Schalkwyk A; Ferreira ML; Romito M
    J Virol Methods; 2019 Apr; 266():89-94. PubMed ID: 30721715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of three triplex real-time reverse transcription PCR assays for the qualitative molecular typing of the nine serotypes of African horse sickness virus.
    Weyer CT; Joone C; Lourens CW; Monyai MS; Koekemoer O; Grewar JD; van Schalkwyk A; Majiwa PO; MacLachlan NJ; Guthrie AJ
    J Virol Methods; 2015 Oct; 223():69-74. PubMed ID: 26232526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Microsphere-based Immunoassay for Serological Detection of African Horse Sickness Virus and Comparison with Other Diagnostic Techniques.
    Sánchez-Matamoros A; Beck C; Kukielka D; Lecollinet S; Blaise-Boisseau S; Garnier A; Rueda P; Zientara S; Sánchez-Vizcaíno JM
    Transbound Emerg Dis; 2016 Dec; 63(6):e270-e277. PubMed ID: 25693720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological response of foals to polyvalent and monovalent live-attenuated African horse sickness virus vaccines.
    Crafford JE; Lourens CW; Smit TK; Gardner IA; MacLachlan NJ; Guthrie AJ
    Vaccine; 2014 Jun; 32(29):3611-6. PubMed ID: 24814557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004-2014.
    Weyer CT; Grewar JD; Burger P; Rossouw E; Lourens C; Joone C; le Grange M; Coetzee P; Venter E; Martin DP; MacLachlan NJ; Guthrie AJ
    Emerg Infect Dis; 2016 Dec; 22(12):2087-2096. PubMed ID: 27442883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, Virological and Immunological Responses after Experimental Infection with African Horse Sickness Virus Serotype 9 in Immunologically Naïve and Vaccinated Horses.
    Durán-Ferrer M; Villalba R; Fernández-Pacheco P; Tena-Tomás C; Jiménez-Clavero MÁ; Bouzada JA; Ruano MJ; Fernández-Pinero J; Arias M; Castillo-Olivares J; Agüero M
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.